# India DNA Synthesis Market > India DNA Synthesis Market Research Report: Size, Share, Trend Analysis By Applications (Gene Therapy, Synthetic Biology, Molecular Diagnostics, Vaccine Development), By Product Type (Oligonucleotides, Gene Fragments, Gene Libraries), By End Users (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Clinical Laboratories) and By Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, PCR-Based Synthesis) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 15.8% - **2024:** $ 181.36 Million - **2025:** $ 210.01 Million - **2035:** $ 910.81 Million - **Key Players:** Thermo Fisher Scientific (US), Illumina (US), Integrated DNA Technologies (US), Eurofins Genomics (DE), GenScript (CN), Twist Bioscience (US), Bioneer (KR), DNA Script (FR), Synthego (US) **Report ID:** MRFR/MED/50503-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-dna-synthesis-market-52261 --- ## Market Summary ## **India DNA Synthesis Market Overview** As per MRFR analysis, the India DNA Synthesis Market Size was estimated at 265 (USD Million) in 2023. The India DNA Synthesis Market Industry is expected to grow from 289.38(USD Million) in 2024 to 823.12 (USD Million) by 2035. The India DNA Synthesis Market CAGR (growth rate) is expected to be around 9.97% during the forecast period (2025 - 2035) **Key India DNA Synthesis Market Trends Highlighted** The India DNA synthesis market is experiencing a transformation driven by several key market drivers. Increased investment in biotechnology and life sciences from both the government and private sectors is propelling this trend. The Indian government promotes research and development in genomics as part of its initiatives to enhance healthcare and agriculture through programs like the National Biotechnology Development Strategy. Furthermore, the growth of personalized medicine is fostering a demand for DNA synthesis services, as researchers and clinicians seek tailored treatment options.  Opportunities abound in the field of synthetic biology and genomics in India, particularly in the agricultural sector, where genetic modifications can lead to higher-yielding crops and disease-resistant plants.This aligns with the government’s push for sustainable agriculture, making it a fertile ground for innovation in DNA synthesis techniques. In addition, the rising prevalence of genetic disorders has led to increased genomic research, thereby stimulating demand for DNA synthesis applications in diagnostics and therapeutics, representing a significant opportunity for growth in the market.  In recent times, there has been a noticeable trend towards collaboration between academic institutions, research organizations, and industry players in India. These partnerships are fostering innovation and enhancing capabilities in DNA synthesis technology. Moreover, the awareness of bioethical considerations and regulatory frameworks surrounding genetic research is evolving, further shaping the market landscape.This collective momentum is positioning India as an emerging hub for advancements in DNA synthesis and biotechnology, promoting sustainable and impactful solutions for health and agriculture on both domestic and global fronts. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India DNA Synthesis Market Drivers** **Increasing Research and Development Activities** The growing research and development (R&D) efforts in both the academic and commercial sectors are contributing to a notable uptick in the India DNA Synthesis Market Industry. The Indian government has been investing heavily in genomics and biotechnology; by 2025, the Department of Biotechnology intends to spend more than 23 billion Indian rupees on genetic engineering and genomics research and development. Additionally, Indian biotech companies have been pushed to do considerable in-house research and development by efforts such as the 'Make in India' campaign.  Gene synthesis is receiving more attention from well-known institutions like the Indian Institute of Science and other biotechnology companies, which is boosting market innovation and capacity. This increased focus on research and development is essential since it results in more effective synthesis methods, which in turn fuel demand in the India DNA Synthesis Market. **Rising Applications in Healthcare and Personalized Medicine** The application of DNA synthesis technology in healthcare, particularly for personalized medicine, is significantly influencing the India DNA Synthesis Market Industry. With the prevalence of chronic diseases on the rise, as evidenced by the Indian Ministry of Health and Family Welfare reporting that non-communicable diseases account for about 62% of all deaths in India, there is an increasing need for tailored therapeutic solutions.  Organizations like the Genome Valley in Hyderabad are actively conducting research on genomic medicine, ushering in innovative treatments that directly heighten the demand for synthesized DNA.The growing need for targeted therapies is making personalized medicine a pivotal segment, thereby propelling market growth in DNA synthesis. **Government Initiatives and Support for Biotechnology** Government support plays a vital role in the expansion of the India DNA Synthesis Market Industry. The Indian government has implemented various policies and schemes aimed at promoting biotechnology, such as the Biotech Policy and the establishment of Biotechnology Incubation Centers. These initiatives aim to create a robust infrastructure for biotech innovation, fostering an environment conducive to growth in DNA synthesis technologies.  Additionally, the Biotechnology Industry Research Assistance Council provides funding support for projects that focus on genetic engineering, thereby incentivizing companies to invest in DNA synthesis.This strong backing promotes market stability and encourages advancements in the DNA synthesis process across the region. **Growing Biomedical and Agricultural Biotechnology Applications** The application of DNA synthesis in both biomedical and agricultural biotechnology is a major driver for the India DNA Synthesis Market Industry. With the Agricultural and Processed Food Products Export Development Authority noting an increase in demand for genetically modified crops, there is a marked rise in the need for efficient DNA synthesis technologies to improve crop resilience and yield.  Additionally, advancements in synthetic biology are leading to innovative solutions in disease management and pharmaceuticals.Major agricultural firms in India are adopting DNA synthesis services for crop improvement programs, thereby expanding the market's reach and applications. This growing intersection of technology and agriculture further amplifies the potential of the India DNA Synthesis Market Industry. **India DNA Synthesis Market Segment Insights** **DNA Synthesis Market Application Insights** The Application segment of the India DNA Synthesis Market showcases a dynamic landscape driven by advancements in biotechnology and increasing demand for innovative solutions in healthcare. The Gene Therapy domain is gaining traction due to its potential to treat genetic disorders, offering new therapeutic avenues. This is particularly significant in India, where genetic diseases pose a substantial public health challenge, and ongoing research is being bolstered by government initiatives such as the National Biotechnology Development Strategy.  Synthetic Biology stands out as another critical area, contributing to the development of bio-based products and sustainable practices, aligning with global goals of environmental sustainability and food security.The focus on engineering biological systems presents lucrative opportunities for industries ranging from agriculture to pharmaceuticals. Molecular Diagnostics is becoming increasingly vital in India, especially in the context of personalized medicine. This segment allows for precise disease detection and treatment planning, addressing the healthcare needs of a growing population.  Moreover, the COVID-19 pandemic has accelerated investments in molecular diagnostics, highlighting the importance of rapid and accurate testing methods. Vaccine Development remains a pivotal application within the market, with India being a global hub for vaccine research and manufacturing.The country’s extensive experience in vaccine production positions it as a leader in the development of both traditional and mRNA vaccines, reflecting its capability to respond swiftly to public health needs. Overall, the Application segment is characterized by a robust interplay of innovation and necessity, reflecting India's dedication to enhancing its biotechnology capabilities while addressing significant health challenges.  The collective growth in these areas not only signifies the potential for economic growth but also portrays a commitment to improving health outcomes across the nation.As a result, the India DNA Synthesis Market exhibits a diverse and evolving landscape that is set to play a pivotal role in future biotechnological advancements. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **DNA Synthesis Market Product Type Insights** The India DNA Synthesis Market encompasses several vital product types, with Oligonucleotides, Gene Fragments, and Gene Libraries playing essential roles in the growth of the industry. Oligonucleotides are significant due to their application in various biotechnology and pharmaceutical sectors, driving research and development in gene therapies and diagnostics. Gene Fragments contribute to advancements in synthetic biology and genomics, facilitating the construction of entire genes and complex pathways, which are crucial for personalized medicine and synthetic organisms.Gene Libraries serve as extensive resources for researchers to explore genetic variability and function, aiding in drug discovery and functional genomics.  Together, these product types reflect a dynamic landscape where innovative technologies and scientific discoveries are advancing the capabilities of genetic research in India. The growth in these segments is also supported by increasing investment from the government and private sectors in biotechnology, alongside a rising demand for personalized healthcare solutions. This market's promising outlook demonstrates the integral role of these product types in shaping the future of genomics and biotechnology in India. **DNA Synthesis Market End User Insights** The India DNA Synthesis Market is significantly influenced by its End User landscape, which comprises Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Academic Research Institutions play a crucial role in driving innovations and enhancing scientific knowledge through advanced research initiatives, leading to a growing demand for DNA synthesis products. Pharmaceutical Companies leverage these services for drug development and genomic studies, promoting the integration of DNA synthesis in therapeutic applications, thus expanding their research capabilities. Biotechnology Companies contribute to the market by focusing on synthetic biology and genetic engineering, where DNA synthesis is essential for developing new products and solutions. Clinical Laboratories utilize DNA synthesis for diagnostics, personalized medicine, and genetic testing, ensuring that patient care is tailored and effective. As the India DNA Synthesis Market evolves, these End Users are essential to harnessing advancements in genetic research, ultimately pushing the industry towards greater heights in innovation and application, reflecting an overall growth trend within the sector. **DNA Synthesis Market Technology Insights** The India DNA Synthesis Market, particularly within the Technology segment, is evolving rapidly as advancements in molecular biology and genomics drive growth in this field. Solid-Phase Synthesis has emerged as a prominent method due to its efficiency and scalability, enabling reliable production of oligonucleotides for various applications, including therapeutics and Research and Development. Liquid-Phase Synthesis presents alternative benefits as it often allows for more flexibility in reaction conditions, becoming significant for specific biochemical assays and research applications. Additionally, PCR-Based Synthesis plays a crucial role as a widely adopted technique that enhances the accessibility and practicality of DNA synthesis in laboratories across India. The increasing focus on personalized medicine and rising investments in biotechnology are strengthening the relevance of these technologies, reinforcing the segmentation within the India DNA Synthesis Market. The collective influence of these methodologies demonstrates their integral role in expanding the overall industry, catering to diverse needs ranging from diagnostics to therapeutic developments in the country. **India DNA Synthesis Market Key Players and Competitive Insights** The India DNA Synthesis Market has emerged as a rapidly evolving sector within the biotechnology landscape, characterized by dynamic competition and an influx of innovative technologies. As the demand for synthetic DNA rises across various applications such as genomics, diagnostics, and therapeutic development, numerous firms have ventured into this domain. Key players in this market are continuously enhancing their capabilities through technological advancements, strategic collaborations, and the development of comprehensive service offerings. The growing investment in research and development, particularly in genomics and synthetic biology, further intensifies competition among market participants.  With the expanding biotechnology ecosystem in India, understanding the competitive insights provides invaluable information for stakeholders looking to navigate this promising yet complex environment.Twist Bioscience has established a significant presence in the India DNA Synthesis Market with its advanced synthetic DNA platform, which is based on a unique silicon-based DNA synthesis technology. This innovative approach allows for high-quality, high-throughput synthesis of DNA, making Twist Bioscience a strong competitor in the field. The company has fortified its position by offering services that cater to a variety of applications, including gene synthesis, oligonucleotide production, and libraries for drug discovery and development.  The ability of Twist Bioscience to capture and efficiently meet the diverse needs of customers in India has contributed to its reputation as a reliable partner in biotechnology. Moreover, its commitment to maintaining high-quality standards and rapid turnaround times further enhances its attractiveness in the market.GenScript has established itself as a prominent player in the India DNA Synthesis Market, providing a comprehensive range of products and services that cater to researchers and organizations involved in genetic research and biotechnology. The company specializes in gene synthesis, peptide synthesis, and antibody services, thus offering a well-rounded portfolio to its customers. GenScript's strengths lie in its robust production capabilities and commitment to quality, which allow for the reliable synthesis of complex DNA sequences tailored to specific research needs.  The company's strategic moves in expanding its presence in India demonstrate its focus on leveraging local market opportunities. GenScript has also engaged in various collaborations and partnerships to enhance its service offerings in India, positioning itself as a key player in the biotechnology supply chain. Its emphasis on customer-centric solutions and technological advancements ensures that GenScript remains competitive in the evolving landscape of DNA synthesis within the region. **Key Companies in the India DNA Synthesis Market Include** **India DNA Synthesis Market Industry Developments** The India DNA Synthesis Market has witnessed significant developments recently, particularly with companies like Twist Bioscience and GenScript leading advancements in synthetic biology. In October 2023, DNA2.0 announced a partnership with Bharat Biotech to enhance vaccine development processes, reflecting the growing collaboration within the biotechnology sector. Also, SigmaAldrich has expanded its product offerings in India, catering to the increasing demand for synthetic DNA solutions. Integrated DNA Technologies and Hera BioLabs have recently invested in new facilities to scale up their operations in India, anticipating a surge in demand for synthetic genes and oligonucleotides.  Furthermore, in August 2023, Thermo Fisher Scientific opened a new distribution center in India to streamline its supply chain for reagents and consumables. The market is projected to experience a robust growth trajectory, bolstered by the rise of biotechnology research initiatives supported by Indian government policies. Recent trends indicate that key players like Biocon and Strand Life Sciences are also focusing on research and development, which is expected to further escalate market valuation. Over the past two to three years, the sector has expanded due to increased investment in genomics and personalized medicine in India. **India DNA Synthesis Market Segmentation Insights** ## Market Drivers ### Advancements in Biotechnology The dna synthesis market in India is experiencing a surge due to rapid advancements in biotechnology. Innovations in gene editing technologies, such as CRISPR, are driving the demand for custom DNA synthesis services. As research institutions and biotech companies increasingly adopt these technologies, the need for high-quality synthetic DNA is becoming paramount. The Indian biotechnology sector is projected to reach $100 B by 2025, indicating a robust growth trajectory. This growth is likely to enhance the capabilities of local firms in the dna synthesis market, enabling them to offer more sophisticated and tailored solutions to researchers and developers. Furthermore, collaborations between academic institutions and industry players are fostering an environment conducive to innovation, thereby propelling the dna synthesis market forward. ### Rising Applications in Agriculture The application of synthetic DNA in agriculture is emerging as a significant driver for the dna synthesis market in India. With the increasing need for food security and sustainable agricultural practices, synthetic biology is being leveraged to develop genetically modified crops that are resistant to pests and diseases. The Indian agricultural biotechnology market is expected to reach $10 B by 2025, indicating a substantial opportunity for dna synthesis providers. This trend suggests that agricultural research institutions and companies will increasingly seek custom DNA synthesis services to create improved crop varieties. As the demand for sustainable agricultural solutions rises, the dna synthesis market is likely to benefit from increased collaborations with agricultural stakeholders. ### Growing Investment in Genomic Research Investment in genomic research is a key driver for the dna synthesis market in India. The government and private sectors are increasingly funding initiatives aimed at understanding genetic diseases and developing personalized medicine. In 2025, the Indian government allocated approximately $1 B to genomics research, reflecting a commitment to advancing healthcare through genetic insights. This influx of capital is likely to stimulate demand for synthetic DNA, as researchers require custom sequences for their studies. Additionally, the rise of startups focused on genomics is contributing to a competitive landscape, further driving innovation and efficiency in the dna synthesis market. As more projects emerge, the need for reliable and scalable DNA synthesis solutions will continue to grow. ### Regulatory Support for Biotech Innovations Regulatory frameworks in India are evolving to support innovations in biotechnology, which is positively impacting the dna synthesis market. The government is implementing policies that encourage research and development in synthetic biology, thereby creating a favorable environment for market growth. Initiatives such as the Biotechnology Industry Research Assistance Council (BIRAC) are providing funding and resources to startups and established companies alike. This regulatory support is likely to enhance the capabilities of firms in the dna synthesis market, allowing them to innovate and expand their service offerings. As regulations become more conducive to biotech advancements, the market is expected to witness increased activity and investment. ### Collaboration Between Academia and Industry The collaboration between academic institutions and industry players is a crucial driver for the dna synthesis market in India. Universities and research organizations are increasingly partnering with biotech companies to translate scientific discoveries into practical applications. This synergy is fostering innovation and accelerating the development of new technologies in dna synthesis. In 2025, it is estimated that over 60% of research projects in biotechnology will involve collaborations with industry, highlighting the importance of these partnerships. Such collaborations not only enhance the research capabilities of academic institutions but also provide industry players with access to cutting-edge research, thereby driving growth in the dna synthesis market. ## Future Outlook The [DNA synthesis Market](https://www.marketresearchfuture.com/reports/dna-synthesis-market-20306) in India is poised for growth at a 15.8% CAGR from 2025 to 2035, driven by advancements in biotechnology, increased R&D investments, and rising demand for personalized medicine. **New opportunities:** - Development of customized DNA synthesis platforms for niche applications. - Expansion of partnerships with biotech firms for co-development projects. - Implementation of AI-driven analytics for optimizing synthesis processes. By 2035, the DNA synthesis market is expected to achieve substantial growth, reflecting robust demand and innovation. ## Segment Insights ### By Application: Gene Therapy (Largest) vs. Vaccine Development (Fastest-Growing) In the application segment of the India India DNA Synthesis Market, Gene Therapy dominates with the largest market share due to its critical role in treating genetic disorders. Following closely are Synthetic Biology and Molecular Diagnostics, which capture significant portions of the market, but Gene Therapy remains at the forefront. Vaccine Development, meanwhile, is rapidly gaining traction as a significant player as the demand for innovative vaccine solutions surges. Growth trends in this market segment are largely driven by advancements in genetic research and technology, particularly in the fields of biotechnology and genomic medicine. The increasing prevalence of genetic disorders and infectious diseases highlights the need for effective therapeutic solutions, propelling the Gene Therapy segment. Concurrently, Vaccine Development is emerging as the fastest-growing area, fueled by the urgency for rapidly deployable and effective vaccines in response to global health challenges. Gene Therapy (Dominant) vs. Vaccine Development (Emerging) Gene Therapy is positioned as the dominant segment within the India dna synthesis market, leveraging cutting-edge techniques to address complex genetic conditions. It showcases substantial advancements in therapy effectiveness and delivery mechanisms, appealing to both researchers and healthcare providers. Vaccine Development, on the other hand, represents an emerging segment that is capitalizing on the increasing global need for innovative vaccines. With a focus on rapid development and scalability, this segment is attracting significant investment and research efforts, particularly in light of recent public health challenges. Both segments illustrate the dynamic nature of the market, driven by technological innovation and the urgent need for comprehensive healthcare solutions. ### By Product Type: Oligonucleotides (Largest) vs. Gene Fragments (Fastest-Growing) In the India India DNA Synthesis Market, the product type segment is prominently led by oligonucleotides, which hold a substantial share due to their critical role in various applications such as diagnostics and therapeutics. Gene fragments and gene libraries follow, reflecting the diverse applications of these products in scientific research and biotechnology innovations. The distribution indicates a clear preference among users for oligonucleotides, showcasing their established utility in the industry. The growth trends in the product type segment are largely driven by increasing investments in biotechnology and personalized medicine. The rising demand for advanced genetic research tools is propelling the growth of gene fragments as the fastest-growing segment. Furthermore, the expansion of genomics and proteomics research activities fosters a supportive environment for gene libraries, which are becoming increasingly essential for innovative applications. Oligonucleotides (Dominant) vs. Gene Fragments (Emerging) Oligonucleotides serve as a dominant force in the India dna synthesis market, characterized by their versatility in applications ranging from gene silencing to PCR amplification. Their established presence is supported by a broad range of uses in both research and clinical settings, leading to a favored market position. In contrast, gene fragments, while emerging, are rapidly gaining traction due to their role in custom gene synthesis and synthetic biology applications. The demand for bespoke genetic materials is escalating, positioning gene fragments as a key area of growth. As research methodologies evolve, both segments are poised to address the diverse needs of the biotechnology sector. ### By End User: Pharmaceutical Companies (Largest) vs. Academic Research Institutions (Fastest-Growing) In the India India DNA Synthesis Market, Pharmaceutical Companies hold the largest share, driven by their emphasis on research and development for new drug formulations. Academic Research Institutions, however, are emerging rapidly as a significant player in the market due to increasing funding for genomic research and rising educational initiatives. Each segment plays a crucial role in shaping the market landscape and fostering innovation within the industry. Growth trends indicate that the demand for dna synthesis is swiftly increasing, particularly among Academic Research Institutions, which are leveraging advancements in technology to enhance their capabilities. On the other hand, Pharmaceutical Companies focus on streamlining their development processes, thus bolstering their market presence. Factors such as collaborations, technological advancements, and the increasing need for personalized medicine are key drivers influencing growth in this segment. Pharmaceutical Companies (Dominant) vs. Academic Research Institutions (Emerging) Pharmaceutical Companies are dominant in the India dna synthesis market, characterized by robust investment in research and development and a focus on innovative therapies. Their ability to synthesize complex dna sequences allows them to accelerate the drug development process and meet stringent regulatory requirements. In contrast, Academic Research Institutions are emerging as a vital segment due to heightened interest in genetic studies and the role of dna synthesis in advancing scientific discovery. These institutions often collaborate with industry partners, driving advancements and creating applications in biotechnology. As educational funding increases, these institutions will likely continue to expand their market impact, contributing to the overall growth of the sector. ### By Technology: Solid-Phase Synthesis (Largest) vs. PCR-Based Synthesis (Fastest-Growing) In the India India DNA Synthesis Market, Solid-Phase Synthesis leads with a significant market share, dominating the landscape due to its efficiency and reliability in producing high-quality oligonucleotides. Liquid-Phase Synthesis follows, offering flexibility in synthesis but lacks the robustness that solid-phase methods provide. Meanwhile, PCR-Based Synthesis has emerged as a vital player, capturing attention for its rapid cycle times and adaptability in various applications, positioning it as a key growth driver. Growth trends indicate a robust expansion in the sector, primarily propelled by increasing applications in research, diagnostics, and therapeutics. The demand for rapid results and mass production capabilities fuels the rise of PCR-Based Synthesis, while Solid-Phase Synthesis continues to thrive due to its established methods. Overall, innovations in synthesis technologies and rising investments will further enhance market competitiveness moving forward. Technology: Solid-Phase Synthesis (Dominant) vs. PCR-Based Synthesis (Emerging) Solid-Phase Synthesis stands out in the India dna synthesis market for its dominant position, offering high-throughput capabilities that satisfy the increasing demand for synthesized DNA in various scientific endeavors. Its well-understood protocols have enabled consistent results, forming the backbone of many commercial applications. On the other hand, PCR-Based Synthesis is recognized as an emerging technology, characterized by its ability to produce DNA rapidly, making it highly desirable in fields that require quick turnaround times such as clinical diagnostics and genetic research. The adaptability of PCR methods allows for customization in synthesis, contributing to its fast-growing acceptance among researchers and industry professionals alike. ### DNA Synthesis Market Technology Insights DNA Synthesis Market Technology Insights The India DNA Synthesis Market, particularly within the Technology segment, is evolving rapidly as advancements in molecular biology and genomics drive growth in this field. Solid-Phase Synthesis has emerged as a prominent method due to its efficiency and scalability, enabling reliable production of oligonucleotides for various applications, including therapeutics and Research and Development. Liquid-Phase Synthesis presents alternative benefits as it often allows for more flexibility in reaction conditions, becoming significant for specific biochemical assays and research applications. Additionally, PCR-Based Synthesis plays a crucial role as a widely adopted technique that enhances the accessibility and practicality of DNA synthesis in laboratories across India. The increasing focus on personalized medicine and rising investments in biotechnology are strengthening the relevance of these technologies, reinforcing the segmentation within the India DNA Synthesis Market. The collective influence of these methodologies demonstrates their integral role in expanding the overall industry, catering to diverse needs ranging from diagnostics to therapeutic developments in the country. ## Competitive Benchmarking The dna synthesis market in India is characterized by a dynamic competitive landscape, driven by advancements in biotechnology and increasing demand for synthetic biology applications. Key players such as Thermo Fisher Scientific (US), Illumina (US), and GenScript (CN) are strategically positioned to leverage innovation and regional expansion. Thermo Fisher Scientific (US) focuses on enhancing its product portfolio through continuous innovation, while Illumina (US) emphasizes partnerships to expand its market reach. GenScript (CN) is actively pursuing mergers and acquisitions to bolster its capabilities, thereby shaping a competitive environment that is increasingly collaborative yet fiercely competitive. In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a market that is moderately fragmented. The collective influence of these key players is significant, as they not only drive technological advancements but also set industry standards that smaller firms must adhere to. This competitive structure fosters an environment where innovation is paramount, and companies are incentivized to differentiate themselves through unique offerings and operational efficiencies. In October 2025, Thermo Fisher Scientific (US) announced the launch of a new line of custom oligonucleotides aimed at enhancing gene editing applications. This strategic move is likely to strengthen its position in the market by catering to the growing demand for precision tools in genetic research. The introduction of these products aligns with the company's focus on innovation and could potentially capture a larger share of the market by appealing to researchers seeking cutting-edge solutions. In September 2025, Illumina (US) entered into a strategic partnership with a leading Indian biotech firm to co-develop next-generation sequencing technologies tailored for local applications. This collaboration not only enhances Illumina's market presence but also demonstrates its commitment to regional adaptation, which is essential in a diverse market like India. Such partnerships are indicative of a broader trend where companies seek to localize their offerings to better meet the needs of specific markets. In August 2025, GenScript (CN) completed the acquisition of a prominent Indian biotech company, significantly expanding its operational footprint in the region. This acquisition is strategically important as it allows GenScript to integrate local expertise and resources, thereby enhancing its service offerings and accelerating its growth trajectory in the Indian market. The move reflects a growing trend of consolidation within the industry, as companies seek to enhance their competitive edge through strategic acquisitions. As of November 2025, current trends in the dna synthesis market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into research and development processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, shifting from price-based competition to a focus on technological advancements, reliability in supply chains, and sustainable practices. This transition underscores the importance of innovation as a key driver of success in the evolving landscape. ## Recent News & Developments The India DNA Synthesis Market has witnessed significant developments recently, particularly with companies like Twist Bioscience and GenScript leading advancements in synthetic biology. In October 2023, DNA2.0 announced a partnership with Bharat Biotech to enhance vaccine development processes, reflecting the growing collaboration within the biotechnology sector. Also, SigmaAldrich has expanded its product offerings in India, catering to the increasing demand for synthetic DNA solutions. Integrated DNA Technologies and Hera BioLabs have recently invested in new facilities to scale up their operations in India, anticipating a surge in demand for synthetic genes and oligonucleotides.  Furthermore, in August 2023, Thermo Fisher Scientific opened a new distribution center in India to streamline its supply chain for reagents and consumables. The market is projected to experience a robust growth trajectory, bolstered by the rise of biotechnology research initiatives supported by Indian government policies. Recent trends indicate that key players like Biocon and Strand Life Sciences are also focusing on research and development, which is expected to further escalate market valuation. Over the past two to three years, the sector has expanded due to increased investment in genomics and personalized medicine in India. ## Report Scope | MARKET SIZE 2024 | 181.36(USD Million) | | --- | --- | | MARKET SIZE 2025 | 210.01(USD Million) | | MARKET SIZE 2035 | 910.81(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 15.8% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Thermo Fisher Scientific (US), Illumina (US), Integrated DNA Technologies (US), Eurofins Genomics (DE), GenScript (CN), Twist Bioscience (US), Bioneer (KR), DNA Script (FR), Synthego (US) | | Segments Covered | Application, Product Type, End User, Technology | | Key Market Opportunities | Advancements in personalized medicine drive demand for tailored solutions in the dna synthesis market. | | Key Market Dynamics | Rising demand for personalized medicine drives innovation and competition in the DNA synthesis market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India DNA synthesis market?** A: The overall market valuation was $181.36 Million in 2024. **Q: What is the projected market size for the India DNA synthesis market by 2035?** A: The projected valuation for 2035 is $910.81 Million. **Q: What is the expected CAGR for the India DNA synthesis market during 2025 - 2035?** A: The expected CAGR for the market during this period is 15.8%. **Q: Which application segments are driving growth in the India DNA synthesis market?** A: Key application segments include Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development. **Q: What are the estimated market values for the Synthetic Biology segment?** A: The Synthetic Biology segment is estimated to grow from $50.0 Million to $250.0 Million. **Q: Who are the leading companies in the India DNA synthesis market?** A: Key players include Thermo Fisher Scientific, Illumina, Integrated DNA Technologies, and GenScript. **Q: What product types are prevalent in the India DNA synthesis market?** A: Prominent product types include Oligonucleotides, Gene Fragments, and Gene Libraries. **Q: What is the market value range for Gene Fragments in the India DNA synthesis market?** A: The market value for Gene Fragments ranges from $72.68 Million to $363.4 Million. **Q: Which end users are contributing to the growth of the India DNA synthesis market?** A: End users include Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. **Q: What technology segments are utilized in the India DNA synthesis market?** A: Technology segments include Solid-Phase Synthesis, Liquid-Phase Synthesis, and PCR-Based Synthesis. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-dna-synthesis-market-52261*